56 related articles for article (PubMed ID: 8174474)
1. [Determination on of C/EBP in human liver cancer, normal adult liver and various diseased liver tissues].
Xu LX
Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):332-4. PubMed ID: 8174474
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical demonstration of CCAAT/enhancer binding protein (C/EBP) in human liver tissues of various origin.
Xu LX; Sui YF; Wang WL; Liu YF; Gu JR
Chin Med J (Engl); 1994 Aug; 107(8):596-9. PubMed ID: 7805444
[TBL] [Abstract][Full Text] [Related]
3. [Determination and significance of C/EBP in hepatoma and various liver tissues].
Xu LX; Sui YF; Gu JR
Zhonghua Bing Li Xue Za Zhi; 1994; 23(3):148-50. PubMed ID: 7954953
[TBL] [Abstract][Full Text] [Related]
4. Regenerative changes in C/EBP alpha and C/EBP beta expression modulate binding to the C/EBP site in the c-fos promoter.
Diehl AM; Yang SQ
Hepatology; 1994 Feb; 19(2):447-56. PubMed ID: 8294101
[TBL] [Abstract][Full Text] [Related]
5. Lack of C/EBP alpha gene expression results in increased DNA synthesis and an increased frequency of immortalization of freshly isolated mice [correction of rat] hepatocytes.
Soriano HE; Kang DC; Finegold MJ; Hicks MJ; Wang ND; Harrison W; Darlington GJ
Hepatology; 1998 Feb; 27(2):392-401. PubMed ID: 9462636
[TBL] [Abstract][Full Text] [Related]
6. Topographical immunohistochemical expression of bcl-2 protein in human liver lesions.
Skopelitou A; Hadjiyannakis M; Alexopoulou V; Krikoni O; Kamina S; Agnantis N
Anticancer Res; 1996; 16(2):975-8. PubMed ID: 8687162
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic marker.
Tomizawa M; Watanabe K; Saisho H; Nakagawara A; Tagawa M
Anticancer Res; 2003; 23(1A):351-4. PubMed ID: 12680236
[TBL] [Abstract][Full Text] [Related]
8. [Expression of five different antigens of HBV in human intrahepatic cholangiocarcinoma and cholangiohepatocarcinoma].
Wang WL
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):252-5. PubMed ID: 8174460
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulphate proteoglycan expression in human primary liver tumours.
Roskams T; De Vos R; David G; Van Damme B; Desmet V
J Pathol; 1998 Jul; 185(3):290-7. PubMed ID: 9771483
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study of hepatitis C virus core antigen and HBxAg in liver cirrhosis and hepatocellular carcinoma tissues].
Wang C; Wang W; Lu H
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):85-8. PubMed ID: 10743066
[TBL] [Abstract][Full Text] [Related]
11. The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPbeta during epithelial tumour progression.
Sundfeldt K; Ivarsson K; Carlsson M; Enerbäck S; Janson PO; Brännström M; Hedin L
Br J Cancer; 1999 Mar; 79(7-8):1240-8. PubMed ID: 10098766
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CCAAT/enhancer binding protein isoforms by serum and glucocorticoids in the rat intestinal epithelial crypt cell line IEC-6.
Boudreau F; Blais S; Asselin C
Exp Cell Res; 1996 Jan; 222(1):1-9. PubMed ID: 8549649
[TBL] [Abstract][Full Text] [Related]
13. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
14. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
[TBL] [Abstract][Full Text] [Related]
15. Differential patterns of expression of three C/EBP isoforms, HNF-1, and HNF-4 after partial hepatectomy in rats.
Flodby P; Antonson P; Barlow C; Blanck A; Porsch-Hällström I; Xanthopoulos KG
Exp Cell Res; 1993 Sep; 208(1):248-56. PubMed ID: 8359219
[TBL] [Abstract][Full Text] [Related]
16. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
[TBL] [Abstract][Full Text] [Related]
17. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
[TBL] [Abstract][Full Text] [Related]
18. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I
Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
[TBL] [Abstract][Full Text] [Related]
20. Alteration of expression of liver-enriched transcription factors in the transition between growth and differentiation of primary cultured rat hepatocytes.
Mizuguchi T; Mitaka T; Hirata K; Oda H; Mochizuki Y
J Cell Physiol; 1998 Mar; 174(3):273-84. PubMed ID: 9462689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
